Maternal hypertension, medication use, and hypospadias in the national birth defects prevention study

Obstetrics and Gynecology

Volumn 123, Issue 2, 2014, Pages 309-317

  Van Zutphen, Alissa R ^a,b,c,d   Werler, Martha M ^a,b,c,d   Browne, Marilyn M ^a,b,c,d   Romitti, Paul A ^a,b,c,d   Bell, Erin M ^a,b,c,d   McNutt, Louise Anne ^a,b,c,d   Druschel, Charlotte M ^a,b,c,d   Mitchell, Allen A ^a,b,c,d  

^a NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^b UNIVERSITY AT ALBANY   (United States)

^c BOSTON UNIVERSITY   (United States)

^d UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; ARTICLE; CONGENITAL DISORDER; FEMALE; GESTATIONAL AGE; HUMAN; HYPERTENSION; HYPOSPADIAS; MALE; PREGNANCY; PREGNANCY COMPLICATION; RISK; RISK FACTOR; YOUNG ADULT;

ADRENERGIC BETA-ANTAGONISTS; ADULT; ANTIHYPERTENSIVE AGENTS; CONGENITAL ABNORMALITIES; FEMALE; GESTATIONAL AGE; HUMANS; HYPERTENSION; HYPOSPADIAS; MALE; ODDS RATIO; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; RISK FACTORS; YOUNG ADULT;

EID: 84893724909     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000000103     Document Type: Article

References (40)

1. Roberts CL, Ford JB, Algert CS, Antonsen S, Chalmers J, Cnattingius S, et al. Population-based trends in pregnancy hypertension and pre-eclampsia: An international comparative study. BMJ Open 2011;1:e000101.
2. Chronic hypertension in pregnancy. Practice Bulletin No. 125. American College of Obstetricians and Gynecologists. Obstet Gynecol 2012;119:369-407.
3. Podymow T, August P. Update on the use of antihypertensive drugs in pregnancy. Hypertension 2008;51:960-9.
4. Kliman HJ. Uteroplacental blood flow. The story of decidualization, menstruation, and trophoblast invasion. Am J Pathol 2000;157:1759-68.
5. Mayhew TM, Charnock-Jones DS, Kaufmann P. Aspects of human fetoplacental vasculogenesis and angiogenesis. III. Changes in complicated pregnancies. Placenta 2004;25:127-39.
6. Culver JC, Dickinson ME. The effects of hemodynamic force on embryonic development. Microcirculation 2010;17:164-78.
7. von Dadelszen P, Magee LA. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: An updated metaregression analysis. J Obstet Gynaecol Can 2002;24: 941-5.
8. Gatti JM, Kirsch AJ, Troyer WA, Perez-Brayfield MR, Smith EA, Scherz HC. Increased incidence of hypospadias in small-for-gestational age infants in a neonatal intensive-care unit. BJU Int 2001;87:548-50.
9. Hussain N, Chaghtai A, Herndon CD, Herson VC, Rosenkrantz TS, McKenna PH. Hypospadias and early gestation growth restriction in infants. Pediatrics 2002;109:473-8.
10. Sun G, Tang D, Liang J, Wu M. Increasing prevalence of hypospadias associated with various perinatal risk factors in Chinese newborns. Urology 2009;73:1241-5.
11. Yinon Y, Kingdom JC, Proctor LK, Kelly EN, Salle JL, Wherrett D, et al. Hypospadias in males with intrauterine growth restriction due to placental insufficiency: The placental role in the embryogenesis of male external genitalia. Am J Med Genet A 2010;152A:75-83.
12. Akre O, Lipworth L, Cnattingius S, Sparén P, Ekbom A. Risk factor patterns for cryptorchidism and hypospadias. Epidemiology 1999;10:364-9.
13. Akre O, Boyd HA, Ahlgren M, Wilbrand K, Westergaard T, Hjalgrim H, et al. Maternal and gestational risk factors for hypospadias. Environ Health Perspect 2008;116:1071-6.
14. Møller H, Weidner IS. Epidemiology of cryptorchidism and hypospadias. Epidemiology 1999;10:352-4.
15. Aschim EL, Haugen TB, Tretli S, Daltveit AK, Grotmol T. Risk factors for hypospadias in Norwegian boys-association with testicular dysgenesis syndrome? Int J Androl 2004;27:213-21.
16. Caton AR, Bell EM, Druschel CM, Werler MM, Mitchell AA, Browne ML, et al. Maternal hypertension, antihypertensive medication use, and the risk of severe hypospadias. Birth Defects Res A Clin Mol Teratol 2008;82:34-40.
17. Brouwers MM, van der Zanden LF, de Gier RP, Barten EJ, Zielhuis GA, Feitz WF, et al. Hypospadias: Risk factor patterns and different phenotypes. BJU Int 2010;105:254-62.
18. Sørensen HT, Pedersen L, Nørgaard M,Wogelius P, Rothman KJ. Maternal asthma, preeclampsia and risk of hypospadias. Epidemiology 2005;16:806-7.
19. Briggs GG, Freeman RK, Yaffe SJ. Beta blockers. Drugs in Pregnancy and Lactation Update 2003;16:10-5.
20. Czeizel A. Teratogenicity of ergotamine. J Med Genet 1989;26: 69-70.
21. Lennestal R, Otterblad Olausson P, Källén B. Maternal use of antihypertensive drugs in early pregnancy and delivery outcome, notably the presence of congenital heart defects in the infants. Eur J Clin Pharmacol 2009;65:615-25.
22. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation. Baltimore (MD): Williams & Wilkins; 1998.
23. Heinonen OP, Slone D, Shapiro S. Birth defects and drugs in pregnancy. Littleton (MA): PSG Publishing Co; 1977.
24. Adams SV, Hastert TA, Huang Y, Starr JR. No association between maternal pre-pregnancy obesity and risk of hypospadias or cryptorchidism in male newborns. Birth Defects Res A Clin Mol Teratol 2011;91:241-8.
25. Cooper WO, Hernandez-Diaz S, Arbogast PG, Dudley JA, Dyer S, Gideon PS, et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 2006; 354:2443-51.
26. Davis RL, Eastman D, McPhillips H, Raebel MA, Andrade SE, Smith D, et al. Risks of congenital malformations and perinatal events among infants exposed to calcium channel and betablockers during pregnancy. Pharmacoepidemiol Drug Saf 2011;20:138-45.
27. Sorensen HT, Czeizel AE, Rockenbauer M, Steffensen FH, Olsen J. The risk of limb deficiencies and other congenital abnormalities in children exposed in utero to calcium channel blockers. Acta Obstet Gynecol Scand 2001;80:397-401.
28. Bánhidy F, Acs N, Puhó EH, Czeizel AE. Chronic hypertension with related drug treatment of pregnant women and congenital abnormalities in their offspring: A population-based study. Hypertens Res 2011;34:257-63.
29. Mitchell AA. Studies of drug-induced birth defects. In: Strom BL, Kimmel SE, Hennessy S, editors. Pharmacoepidemiology. 5th ed. New York (NY): Wiley-Blackwell; 2012. p. 487-504.
30. Yoon PW, Rasmussen SA, Lynberg MC, Moore CA, Anderka M, Carmichael SL, et al. The National Birth Defects Prevention Study. Public Health Rep 2001;116(suppl 1):32-40.
31. Rasmussen SA, Olney RS, Holmes LB, Lin AE, Keppler-Noreuil KM, Moore CA; National Birth Defects Prevention Study. Guidelines for case classification for the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol 2003;67:193-201.
32. Holm S. A simple sequentially rejective Bonferroni test procedure. Scand J Stat 1979;6:65-70.
33. Houlihan DD, Dennedy MC, Ravikumar N, Morrison JJ. Antihypertensive therapy and the feto-placental circulation: Effects on umbilical artery resistance. J Perinat Med 2004;32:315-9.
34. Montan S, Anandakumar C, Arulkumaran S, Ingemarsson I, Ratnam SS. Effects of methyldopa on uteroplacental and fetal hemodynamics in pregnancy-induced hypertension. Am J Obstet Gynecol 1993;168:152-6.
35. Erkinaro T, Kavasmaa T, Ylikauma L, Mäkikallio K, Haapsamo M, Acharya G, et al. Placental and fetal hemodynamics after labetalol or pindolol in a sheep model of increased placental vascular resistance and maternal hypertension. Reprod Sci 2009;16:749-57.
36. Sadler TW. Langman's medical embryology. 9th ed. Baltimore (MD): Lippincott Williams & Wilkins; 2004.
37. Baumhäkel M, Schlimmer N, Kratz M, Hackett G, Jackson G, Böhm M. Cardiovascular risk, drugs and erectile function-a systematic analysis. Int J Clin Pract 2011;65:289-98.
38. el-Sayed MG, el-Sayed MT, Elazab Abd el S, Hefeiz MH, el-Komy AA, Hassan E. Effects of some beta-adrenergic blockers on male fertility parameters in rats. Dtsch Tierarztl Wochenschr 1998;105:10-2.
39. Werler MM, Pober BR, Nelson K, Holmes LB. Reporting accuracy among mothers of malformed and nonmalformed infants. Am J Epidemiol 1989;129:415-21.
40. Paulozzi LJ, Erickson JD, Jackson RJ. Hypospadias trends in two US surveillance systems. Pediatrics 1997;100:831-4.